Palisade Bio Inc [NASDAQ: PALI] gained 11.70% or 0.11 points to close at $1.05 with a heavy trading volume of 10191788 shares. The daily chart for PALI points out that the company has recorded -70.67% loss over the past six months. If we look at
Palisade Bio Inc [NASDAQ: PALI] stock went on a downward path that fall over -5.68% on Thursday, amounting to a one-week price decrease of less than -17.41%. Over the last 12 months, PALI stock dropped by -79.48%. The one-year Palisade Bio Inc stock forecast points
Palisade Bio, Inc. (PALI) stock soared 67.07% in the current-market trading session at the price of $1.34 after it received a letter from FDA to proceed with its clinical trial evaluating LB1148. PALI is a clinical-stage biopharma firm. It produces novel therapies to treat patients
Copyright © 2024, Powered by Smart TechOne
